![]() ![]() Pradaxa (dabigatran) and Xarelto (rivaroxaban) were associated with a similar risk compared with warfarin.Eliquis (apixaban) was associated with reduced risk compared with warfarin.Here is a brief summary of the study's findings concerning the effectiveness of these oral anticoagulants in preventing stroke or systemic embolism: The study was conducted in order to examine the " Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation," as explained by the article's title. ![]() The Journal of the American Heart Association published an article in June of 2016 discussing the findings of their comparative study. However, those in favor of NOACs tout them as safer and more effective than warfarin, citing comparative studies of oral anticoagulants. It costs much less than the newer drugs, and lower cost benefits adherence.It is effective in patients with mechanical heart valves, unlike the newer drugs.Reversing its effects is easy and the newer drugs either have a brand-new reversal agent or none at all.It can be monitored, unlike the newer drugs. ![]()
0 Comments
Leave a Reply. |